Abstract:Human health and safety are seriously threatened by tuberculosis (TB), a chronic infectious illness that is caused by human infection with Mycobacterium tuberculosis and can be classified as either pulmonary or extrapulmonary. [ 1 ] TB is susceptible to the population, has a long duration of illness, is complex, and its pathogenesis is associated with immune regulation and a variety of cytokines. The most common extrapulmonary tuberculosis among them is called TB pleurisy (TP), and its primary clinical sign is called TB pleural effusion (TPE). [ 2 ] Most patients with benign pleural effusion (PE), after receiving timely diagnosis and treatment, can see a significant reduction or even complete subsidence of pleural fluid (PF). However, there exists a portion of patients with PE whose condition is difficult to obtain a clear diagnosis through conventional testing methods, and this diagnostic uncertainty may lead to a delay in treatment, which may seriously affect the prognosis of the patient, or worse, may lead to the death of the patient as a result. [ 3 ] Traditional diagnostic methods are not only invasive but also expensive, and these problems need to be addressed. Therefore, new laboratory examination techniques and testing indexes are particularly important in order to help make an effective diagnosis of TPE in a wider and more timely manner and to detect, diagnose, and treat the disease as early as possible. [ 4 ] In recent years, the development and application of immunological examination methods have provided new perspectives and tools in the clinic, and it has been confirmed that TB is closely associated with Th cell immunity in the human immune system. [ 5 ] The body's immunological stability is largely dependent on the balance of Th1 and Th2, the 2 primary functional cell types. Th1 cells produce interferon-gamma (IFN-γ) after activation, which promotes the immune response, has antiviral and macrophage activation functions, and is of discriminatory value in the diagnosis of TPE. [ 6 ] Interleukin-33 (IL-33) is critical in Th1-mediated immune response. Interleukin-35 (IL-35) is involved in T-cell immunity and can be used as a new biomarker for adjunctive diagnosis of TPE. [ 7 , 8 ] There is no study to investigate the effect of combined assay (CA) of IL-35, IL-33, and IFN-γ on the diagnosis of TPE, so it is particularly important to comprehensively analyze their concentrations. Thus, the concentrations of IL-35, IL-33, and IFN-γ are important for the diagnosis of TPE, but no study exists that analyzes the effect of CA of the 3. Therefore, the study discusses the diagnostic effect of TPE by the concentration content of the 3 CAs.

Clinical value of CD97 and CD55 levels in the differential diagnosis of tuberculous and malignant pleural effusions

Significance of serum and pleural effusion levels of related factors in differential diagnosis of tuberculosis and malignant tumor

The Diagnostic Value of MCP-1 and RANTES in Tuberculosis and Malignant Pleural Effusion

Clinical Value of Haptoglobin and Soluble CD163 Testing for the Differential Diagnosis of Tuberculous and Malignant Pleural Effusions.

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Diagnostic Value of Interleukin 22 and Carcinoembryonic Antigen in Tuberculous and Malignant Pleural Effusions

Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.

Expressions and diagnostic value of the cytokines in tuberculous and malignant pleural effusion

Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusion

Level of IL-27 in Tuberculous Pleural Effusion and Its Clinical Implications

The expression levels of VEGF and ICAM-1 in pleural effusion

The diagnostic value and validation of Th17-related cytokines in tuberculosis pleural effusion

Differential Diagnostic Value of IGFBP-2 and CEA between Malignant and Tuberculous Pleural Effusion

Combined Detection of Carcinoembryonic Antigen and C-reactive Protein in Identifying Benign and Malignant Pleural Effusion

Diagnostic Performance of CTLA-4, Carcinoembryonic Antigen and CYFRA 21-1 for Malignant Pleural Effusion

Cell Origins and Diagnostic Accuracy of Interleukin 27 in Pleural Effusions.

Expressions of Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Α,cd1a and Γδtcr+ T in Pleural Effusion and Peripheral Blood and Their Diagnostic Value Analysis for Tuberculosis and Lung Cancer

[Level of Soluble Programmed Death Ligand 1 in Pleural Effusion and Peripheral Blood of Patients with Tuberculous Pleural Effusion and Its Clinical Implications].

Positive Expression of Gamma/delta TCR T Cell and CD1a Molecule in Pleural Effusion and Peripheral Blood

Role of IFN-γ, IL-33, and IL-35 concentrations in tuberculous pleural effusion in diagnosis and analysis of the effectiveness of combined tests

Differential Levels of Cytokines and Soluble Fas Ligand Between Tuberculous and Malignant Effusions.